These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 947320)

  • 1. [On the development of oral preparations of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
    Dechow HJ; Dölcher D; Hübner G; Kim S; Lämmerhirt K; Pich CH; Schmidt-Böthelt E
    Arzneimittelforschung; 1976; 26(42):596-613. PubMed ID: 947320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic studies with the combination sulfamoxole/trimethoprim in animals and men (author's transl)].
    Kuhne J; Kohlmann FW; Seydel JK; Wempe E
    Arzneimittelforschung; 1976; 26(42):651-7. PubMed ID: 947326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxicological investigations of the combination sulfamoxole/trimethoprim, a new broad-spectrum chemotherapeutic (author's transl)].
    Lagler F; Kretzschmar R; Leuschner F; Foitzik E; Kiel H; Kuhne J; Neumann W
    Arzneimittelforschung; 1976; 26(42):634-43. PubMed ID: 947324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigations on the effect of the combination sulfamoxole/trimethoprim on fertility and fetal development in rats and rabbits (author's tranls)].
    Helm F; Kretzschmar R; Leuschner F; Neumann W
    Arzneimittelforschung; 1976; 26(42):643-51. PubMed ID: 947325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological investigations with the combination sulfamoxole/trimethoprim, a new broadspectrum chemotherapeutic agent (author's transl)].
    Gries J; Kretzschmar R; Kuhne J; Neumann W; Osterloh G; Scherschlicht R; Worstmann W
    Arzneimittelforschung; 1976; 26(42):623-33. PubMed ID: 947323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial action of the combined preparation sulfamoxole/trimethoprim in vitro (author's transl)].
    Kohlmann FW; Sous H
    Arzneimittelforschung; 1976; 26(42):613-8. PubMed ID: 947321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental studies on the effect of the combination sulfamoxole/trimethoprim on the Toxoplasma infection of the mouse (author's transl)].
    Maier W; Piekarski G
    Arzneimittelforschung; 1976; 26(42):620-2. PubMed ID: 947322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123). 1st communication. Efficacy activity spectrum--resistance in therapy (author's transl)].
    Etzel M; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):661-5. PubMed ID: 782474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the antibacterial activity of the combination sulfamoxole/trimethoprim (CN 3123) (author's transl)].
    Legler F
    Arzneimittelforschung; 1976; 26(42):658-61. PubMed ID: 947327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial action of the combination sulfamoxole/trimethoprim in vivo (author's transl)].
    Kohlmann FW; Sous H
    Arzneimittelforschung; 1976; 26(42):618-20. PubMed ID: 782473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123)/Sixth communication: Results of compatibility of CN 3123 (author's transl)].
    Etzel M; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):678-83. PubMed ID: 782478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123)/Third communication: Clinical results of a field trial with CN 3123 in bronchopulmonary and ENT (ear/nose/throat) infections (author's transl)].
    Etzel M; Neuhof F; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):671-3. PubMed ID: 782475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprin (CN 3123). Fifth communication: Comparison of two double-blind studies with CN 3123 undertaken for demonstration of its efficacy (author's transl)].
    Nijssen J; Schiemann J; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):676-8. PubMed ID: 782477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123)/Fourth communication: Clinical results with CN 3123 in infections of the gastrointestinal tract, the skin and gynecological adnexes (author's transl)].
    Etzel M; Lehmann H; Steiner H; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):674-6. PubMed ID: 782476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123). 2. Results of a multicenter clinical trial of CN 3123 in infections of the kidneys and urinary tract].
    Eckstein E; Etzel M; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):665-70. PubMed ID: 947328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
    Müller F
    Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of biopharmaceutical parameters in drug development (author's transl)].
    Thoma K
    Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of trimethoprim and sulfonamide after administration of trimethoprim-sulfamethoxazole and trimethoprim-sulfamoxole.
    Gupta KC; Desai NK; Paul T; Sheth UK
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):536-7. PubMed ID: 7228448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.
    Wardrop J; Jaber AB; Ayres JW
    Drug Dev Ind Pharm; 1998 Aug; 24(8):729-36. PubMed ID: 9876520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.